Develops drugs which block intracellular signal transduction pathways for treating solid tumors and hematologic malignancies. Includes kits available, technology overview and investor data from Cambridge, Massachusetts. (Nasdaq: ARIA)
Promotes their activated checkpoint therapy platform. Headquartered in Woburn, Massachusetts. (Nasdaq: ARQL)
Produces radiolabeled compounds for diagnostic and therapeutic use in nuclear medicine and oncology. Includes examples that distinguish infection from inflammation, a peptide based on fibrin, and overview of facilities in Kirkland, Québec. [English, French and Spanish]
Genomics-based discovery company focused on development of drugs, crop protection, and plant biotechnology. Overview of research, investor relations and contacts in California and Portland, Oregon. (Nasdaq: EXEL)
Develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. Includes overview of clinical trials, investor information and news from company in Plymouth Meeting, Pennsylvania. (Nasdaq: GENR)
Licenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood, and headquarters in Cambridge, Massachusetts. (Nasdaq: IMGN)
Discovers and develops small molecule therapeutics based upon the genetics of human disease, with emphasis on cell growth inhibitors. Includes clinical pipeline, technology overview and investor relations at Richmond, California. (Nasdaq: ONXX)
Develops proprietary systems utilizing monoclonal antibodies for the targeted delivery of diagnostic and therapeutic substances in oncology. Includes information for investors, and healthcare professionals in the USA, from Princeton, New Jersey. (Nasdaq: CYTO)
Discovers and develops immunologically based therapeutic anticancer products. Includes progress of clinical trials, and data for investors from company based in Seattle, Washington. (Nasdaq: DNDN)
Researches and develops diagnostics and anticancer therapy in humans and other diseases associated with control of cell growth. Laboratories in Oxford, Boulder and Farmingdale, headquartered in Melville, New York. (Nasdaq: OSIP)
Business /
Biotechnology_and_Pharmaceuticals /
Pharmaceuticals /
Research_and_Development
|